ArQule (ARQL)
ArQule Revenue Growth: -36.61%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ARQL Revenue Growth Rankings
| Overall | 3rd percentile | 4210 of 4358 |
| Sector | 8th percentile | 416 of 456 in Healthcare |
| Industry | 17th percentile | 104 of 126 in Biotechnology |
ARQL Revenue Growth Range, Past 5 Years
| Minimum | -62.65% | Dec 2009 |
| Maximum | 667.4% | Dec 2008 |
| Average | 74.79% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these ARQL related companies
ARQL News
$ARQL 200 Day SMA Cross - Price crossed below 200 day SMA (6.1177). Confirmed by volume.
about 9 days ago by TradeIdeasQuant
about 9 days ago by TradeIdeasQuant
ArQule (ARQL), Daiichi Sankyo Say Bivantinib Phase 2 Met Primary Endpoint; to Present Data at ASCO
May 17, 7:36AM Street Insider
May 17, 7:36AM Street Insider
Listen to $ARQL Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3e68
about 24 days ago by earningscast
about 24 days ago by earningscast
$ARQL ArQule now expects to end 2012 with between $121 and $126 million in cash and marketable securities
about 24 days ago by johnkelly
about 24 days ago by johnkelly
$ARQL "We look forward to presenting additional data from this trial at Annual Meeting of the American Society of Clinical Oncology in June
about 24 days ago by johnkelly
about 24 days ago by johnkelly
ArQule Announces Completion of Common Stock Offering with Full Exercise of Option to Purchase Additional Shares
Apr 16, 4:05PM Business Wire
Apr 16, 4:05PM Business Wire
$ARQL company goes up on offering. also, in soviet russia stock trades you!
about 46 days ago by johnkelly
about 46 days ago by johnkelly
ArQule Prices Public Offering of Common Stock; Says 7.15M Shares Priced at $7.30
Apr 11, 7:56AM Benzinga
Apr 11, 7:56AM Benzinga
7 cancer stocks to have on your radar screen before ASCO conf meets in June: $CLDX $ARQL $JNJ $ARIA $AVEO $ARRY $ONTY http://stks.co/3FYc
about 51 days ago by abubnic
about 51 days ago by abubnic
$ARQL http://stks.co/2v6Y Long setup. Biotech name. MACD crossing over.
about 70 days ago by VexTrades
about 70 days ago by VexTrades
ArQule, Inc. to Present at Cowen and Company 32nd Annual Healthcare Conference
Mar 02, 8:30AM Business Wire
Mar 02, 8:30AM Business Wire
Listen to $ARQL Q4 2011 earnings call - live at 09:00 AM, ondemand after - http://stks.co/2d3C
about 87 days ago by earningscast
about 87 days ago by earningscast
Arqule, Inc. (ARQL) Posts Surprise Q4 Profit; Guides FY12 Loss Expectations Narrower than Views
Mar 01, 7:14AM Street Insider
Mar 01, 7:14AM Street Insider
Arqule, Inc. (ARQL) Reports Q4 EPS of $0.07, Offers Strong FY12 Guidance
Mar 01, 7:14AM Street Insider
Mar 01, 7:14AM Street Insider
ArQule, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference
Feb 09, 8:30AM Business Wire
Feb 09, 8:30AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ARQL | 5.87 | +0.05 | +0.86% | 316.69M |
| AROW | 23.85 | -0.05 | -0.21% | 283.82M |
| ARO | 19.19 | +0.17 | +0.89% | 1.554B |
| ARNA | 6.00 | -0.04 | -0.66% | 1.083B |
| ARMH | 23.23 | +0.13 | +0.56% | 10.46B |
| ARLP | 58.99 | +0.17 | +0.29% | 2.176B |
| ARL | 2.69 | +0.00 | +0.00% | 30.99M |
| ARKR | 14.40 | +0.05 | +0.35% | 46.66M |
| ARK | 4.13 | +0.00 | +0.00% | |
| ARII | 21.36 | -0.65 | -2.95% | 456.04M |
